Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (10856)
All Articles published online
|
Featured Article
|
Publishing Process of This Article
|
Jul 24, 2020 (publication date) through Apr 24, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Oncology
ISSN
2218-4333
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Abdel-Latif M, Youness RA. Why natural killer cells in triple negative breast cancer? World J Clin Oncol 2020; 11(7): 464-476 [PMID: 32821652 DOI: 10.5306/wjco.v11.i7.464] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5190/full/v11/i7/464.htm |
| Number | Citing Articles |
| 1 |
Monica M. Rostom, Alaa A. Rashwan, Christina D. Sotiropoulou, Sama Z. Hozayen, Abdelhamid M. Abdelhamid, Miriam Mokhtar Abdelhalim, Omar Eltahtawy, Hadir M. Emara, Noha M. Elemam, Christos K. Kontos, Rana A. Youness. MIAT: A pivotal oncogenic long noncoding RNA tunning the hallmarks of solid malignancies. Translational Oncology 2025; 54: 102329 doi: 10.1016/j.tranon.2025.102329
|
| 2 |
Ana Myriam Lavín-Pérez, Daniel Collado-Mateo, Shaghayegh Abbasi, João B Ferreira-Júnior, Amir Hossein Ahmadi Hekmatikar. Effects of exercise on immune cells with tumor-specific activity in breast cancer patients and survivors: a systematic review and meta-analysis. Supportive Care in Cancer 2023; 31(9) doi: 10.1007/s00520-023-07968-0
|
| 3 |
Karan Mediratta, Sara El-Sahli, Vanessa D’Costa, Lisheng Wang. Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer. Cancers 2020; 12(12): 3529 doi: 10.3390/cancers12123529
|
| 4 |
Leah Moyal, Inesa Navasardyan, Benjamin Bonavida. Successes and Challenges of NK Immunotherapy. 2021; : 387 doi: 10.1016/B978-0-12-824375-6.00017-5
|
| 5 |
A. Dawoud, R.A. Elmasri, A.H. Mohamed, A. Mahmoud, M.M. Rostom, R.A. Youness. Involvement of CircRNAs in regulating The “New Generation of Cancer Hallmarks”: A Special Depiction on Hepatocellular Carcinoma. Critical Reviews in Oncology/Hematology 2024; 196: 104312 doi: 10.1016/j.critrevonc.2024.104312
|
| 6 |
Tatiana Gerashchenko, Anastasia Frolova, Marina Patysheva, Anton Fedorov, Marina Stakheyeva, Evgeny Denisov, Nadezda Cherdyntseva. Breast Cancer Immune Landscape: Interplay Between Systemic and Local Immunity. Advanced Biology 2024; 8(7) doi: 10.1002/adbi.202400140
|
| 7 |
Heba Nafea, Rana A. Youness, Khaled Abou‐Aisha, Mohamed Z. Gad. LncRNA HEIH/miR‐939‐5p interplay modulates triple‐negative breast cancer progression through NOS2‐induced nitric oxide production. Journal of Cellular Physiology 2021; 236(7): 5362 doi: 10.1002/jcp.30234
|
| 8 |
Sherif Ashraf Fahmy, Alyaa Dawoud, Yousra Ahmed Zeinelabdeen, Caroline Joseph Kiriacos, Kerolos Ashraf Daniel, Omar Eltahtawy, Miriam Mokhtar Abdelhalim, Maria Braoudaki, Rana A. Youness. Molecular Engines, Therapeutic Targets, and Challenges in Pediatric Brain Tumors: A Special Emphasis on Hydrogen Sulfide and RNA-Based Nano-Delivery. Cancers 2022; 14(21): 5244 doi: 10.3390/cancers14215244
|
| 9 |
Katarzyna Uchimiak, Anna M. Badowska-Kozakiewicz, Aleksandra Sobiborowicz-Sadowska, Andrzej Deptała. Current State of Knowledge on the Immune Checkpoint Inhibitors in Triple-Negative Breast Cancer Treatment: Approaches, Efficacy, and Challenges. Clinical Medicine Insights: Oncology 2022; 16 doi: 10.1177/11795549221099869
|
| 10 |
Catarina Nascimento, Fernando Ferreira. Tumor microenvironment of human breast cancer, and feline mammary carcinoma as a potential study model. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2021; 1876(1): 188587 doi: 10.1016/j.bbcan.2021.188587
|
| 11 |
RAGHDA A. SOLIMAN, RANA A. YOUNESS, TAMER M. MANIE, EMAD KHALLAF, MOHAMED EL-SHAZLY, MONA ABDELMOHSEN, HEBA HANDOUSSA, MOHAMED Z. GAD. Uncoupling tumor necrosis factor-α and interleukin-10 at tumor immune microenvironment of breast cancer through miR-17-5p/MALAT-1/H19 circuit. BIOCELL 2022; 46(3): 769 doi: 10.32604/biocell.2022.016636
|
| 12 |
Yousra Ahmed ZeinElAbdeen, Amna AbdAlSeed, Rana A. Youness. Decoding Insulin-Like Growth Factor Signaling Pathway From a Non-coding RNAs Perspective: A Step Towards Precision Oncology in Breast Cancer. Journal of Mammary Gland Biology and Neoplasia 2022; 27(1): 79 doi: 10.1007/s10911-022-09511-z
|
| 13 |
Radwa Y. Mekky, Mai F. Ragab, Tamer Manie, Abdelrahman A. Attia, Rana A. Youness. MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer. Translational Oncology 2023; 31: 101653 doi: 10.1016/j.tranon.2023.101653
|
| 14 |
Shashank Kumar, Mohd Shuaib, Kumari Sunita Prajapati, Atul Kumar Singh, Princy Choudhary, Sangeeta Singh, Sanjay Gupta. A candidate triple-negative breast cancer vaccine design by targeting clinically relevant cell surface markers: an integrated immuno and bio-informatics approach. 3 Biotech 2022; 12(3) doi: 10.1007/s13205-022-03140-3
|
| 15 |
Tasneem Abaza, Mostafa K. Abd El-Aziz, Kerolos Ashraf Daniel, Paraskevi Karousi, Maria Papatsirou, Sherif Ashraf Fahmy, Nadia M. Hamdy, Christos K. Kontos, Rana A. Youness. Emerging Role of Circular RNAs in Hepatocellular Carcinoma Immunotherapy. International Journal of Molecular Sciences 2023; 24(22): 16484 doi: 10.3390/ijms242216484
|
| 16 |
Adham H. Mohamed, Tasneem Abaza, Yomna A. Youssef, Mona Rady, Sherif Ashraf Fahmy, Rabab Kamel, Nabila Hamdi, Eleni Efthimiado, Maria Braoudaki, Rana A. Youness. Extracellular vesicles: from intracellular trafficking molecules to fully fortified delivery vehicles for cancer therapeutics. Nanoscale Advances 2025; 7(4): 934 doi: 10.1039/D4NA00393D
|
| 17 |
Lobna Bouzidi, Hana Triki, Slim Charfi, Wala Ben Kridis, Mohamed Derbel, Lobna Ayadi, Tahya Sellami-Boudawara, Boutheina Cherif. Prognostic Value of Natural Killer Cells Besides Tumor-Infiltrating Lymphocytes in Breast Cancer Tissues. Clinical Breast Cancer 2021; 21(6): e738 doi: 10.1016/j.clbc.2021.02.003
|
| 18 |
Nehal M. Atallah, Maria Haque, Cecily Quinn, Michael S. Toss, Shorouk Makhlouf, Asmaa Ibrahim, Andrew R. Green, Mansour Alsaleem, Catrin S. Rutland, Cinzia Allegrucci, Nigel P. Mongan, Emad Rakha. Characterisation of luminal and triple-negative breast cancer with HER2 Low protein expression. European Journal of Cancer 2023; 195: 113371 doi: 10.1016/j.ejca.2023.113371
|
| 19 |
Ramah M. Abdallah , Aisha M. Elkhouly , Raghda A. Soliman , Nehad El Mechawy, Ahmed El Sebaei , Amira A. Motaal , Hesham El-Askary , Rana A. Youness , Reem A. Assal . Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin
Halts Breast Cancer Aggressiveness Through Tuning ICAM-1. Anti-Cancer Agents in Medicinal Chemistry 2022; 22(3): 586 doi: 10.2174/1871520621666210419093652
|
| 20 |
Aya H. Soliman, Rana A. Youness, Aya A. Sebak, Heba Handoussa. Phytochemical-derived tumor-associated macrophage remodeling strategy using Phoenix dactylifera L. boosted photodynamic therapy in melanoma via H19/iNOS/PD-L1 axis. Photodiagnosis and Photodynamic Therapy 2023; 44: 103792 doi: 10.1016/j.pdpdt.2023.103792
|
| 21 |
Asmaa Ramzy, Mohammad Abdel-Halim, Tamer Manie, Noha M. Elemam, Samar Mansour, Rana A. Youness, Aya Sebak. In-vitro immune-modulation of triple-negative breast cancer through targeting miR-30a-5p/MALAT1 axis using nano-PDT combinational approach. Translational Oncology 2025; 55: 102365 doi: 10.1016/j.tranon.2025.102365
|
| 22 |
Eva Kudelova, Marek Smolar, Veronika Holubekova, Andrea Hornakova, Dana Dvorska, Vincent Lucansky, Lenka Koklesova, Erik Kudela, Peter Kubatka. Genetic Heterogeneity, Tumor Microenvironment and Immunotherapy in Triple-Negative Breast Cancer. International Journal of Molecular Sciences 2022; 23(23): 14937 doi: 10.3390/ijms232314937
|
| 23 |
Elio Ibrahim, Ernest Diab, Rony Hayek, Karim Hoyek, Hampig Kourie, Pranshu Sahgal. Triple‐Negative Breast Cancer: Tumor Immunogenicity and Beyond. International Journal of Breast Cancer 2024; 2024(1) doi: 10.1155/2024/2097920
|
| 24 |
Hadir M. Emara, Nageh K. Allam, Rana A. Youness. A comprehensive review on targeted therapies for triple negative breast cancer: an evidence-based treatment guideline. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-02227-6
|
| 25 |
Yiwen Zheng, Shujin Li, Hongchao Tang, Xuli Meng, Qinghui Zheng. Molecular mechanisms of immunotherapy resistance in triple-negative breast cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1153990
|
| 26 |
Bianca C. T. Flores, Smriti Chawla, Ning Ma, Chad Sanada, Praveen Kumar Kujur, Rudy Yeung, Margot B. Bellon, Kyle Hukari, Brian Fowler, Mark Lynch, Ludmilla T. D. Chinen, Naveen Ramalingam, Debarka Sengupta, Stefanie S. Jeffrey. Microfluidic live tracking and transcriptomics of cancer-immune cell doublets link intercellular proximity and gene regulation. Communications Biology 2022; 5(1) doi: 10.1038/s42003-022-04205-y
|
| 27 |
Mustafa Abdel-Latif, Ahmed Riad, Raghda A. Soliman, Aisha M. Elkhouly, Heba Nafae, Mohamed Z. Gad, Amira Abdel Motaal, Rana A. Youness. MALAT-1/p53/miR-155/miR-146a ceRNA circuit tuned by methoxylated quercitin glycoside alters immunogenic and oncogenic profiles of breast cancer. Molecular and Cellular Biochemistry 2022; 477(4): 1281 doi: 10.1007/s11010-022-04378-4
|
| 28 |
Alyaa Dawoud, Zeina Ihab Zakaria, Hannah Hisham Rashwan, Maria Braoudaki, Rana A. Youness. Circular RNAs: New layer of complexity evading breast cancer heterogeneity. Non-coding RNA Research 2023; 8(1): 60 doi: 10.1016/j.ncrna.2022.09.011
|
| 29 |
Dorota Bartusik-Aebisher, Wiktoria Mytych, Klaudia Dynarowicz, Angelika Myśliwiec, Agnieszka Machorowska-Pieniążek, Grzegorz Cieślar, Aleksandra Kawczyk-Krupka, David Aebisher. Magnetic Resonance Imaging in Breast Cancer Tissue In Vitro after PDT Therapy. Diagnostics 2024; 14(5): 563 doi: 10.3390/diagnostics14050563
|
| 30 |
Noha M. Elemam, Rana A. Youness, Abdelhamid M. Abdelhamid, Iman M. Talaat. . Interdisciplinary Cancer Research 2024; doi: 10.1007/16833_2024_429
|
| 31 |
H.H. Rashwan, A.M. Taher, H.A. Hassan, A.A. Awaji, C.J. Kiriacos, R.A. Assal, R.A. Youness. Harnessing the supremacy of MEG3 LncRNA to defeat gastrointestinal malignancies. Pathology - Research and Practice 2024; 256: 155223 doi: 10.1016/j.prp.2024.155223
|
| 32 |
Reem A. Assal, Noha M. Elemam, Radwa Y. Mekky, Abdelrahman A. Attia, Aya Hesham Soliman, Asmaa Ibrahim Gomaa, Eleni K. Efthimiadou, Maria Braoudaki, Sherif Ashraf Fahmy, Rana A. Youness. A Novel Epigenetic Strategy to Concurrently Block Immune Checkpoints PD-1/PD-L1 and CD155/TIGIT in Hepatocellular Carcinoma. Translational Oncology 2024; 45: 101961 doi: 10.1016/j.tranon.2024.101961
|
| 33 |
A.M. Abdelhamid, Y. Zeinelabdeen, T. Manie, E. Khallaf, R.A. Assal, R.A. Youness. miR-17–5p/STAT3/H19: A novel regulatory axis tuning ULBP2 expression in young breast cancer patients. Pathology - Research and Practice 2024; 263: 155638 doi: 10.1016/j.prp.2024.155638
|
| 34 |
Namdev Dhas, Ritu Kudarha, Sanjay Kulkarni, Soji Soman, Prerana D. Navti, Jahnavi Kulkarni, Amrita Arup Roy, Viola Colaco, Ruchira Raychaudhuri, Ashutosh Gupta, Chandrakantsing Pardeshi, Dipak Bari, Ruchi Tiwari, Jayvadan Patel, Sudheer Moorkoth, Srinivas Mutalik. Nanoengineered Platform-Based Microenvironment-Triggered Immunotherapy in Cancer Treatment. Frontiers in Bioscience-Landmark 2024; 29(10) doi: 10.31083/j.fbl2910349
|
| 35 |
Deeptha Ishwar, Srilakshmi Premachandran, Sunit Das, Krishnan Venkatakrishnan, Bo Tan. Profiling Breast Tumor Heterogeneity and Identifying Breast Cancer Subtypes Through Tumor‐Associated Immune Cell Signatures and Immuno Nano Sensors. Small 2024; 20(52) doi: 10.1002/smll.202406475
|
| 36 |
Zundong Liu, Mingji Ding, Pengjun Qiu, Kelun Pan, Qiaonan Guo. Natural killer cell-related prognostic risk model predicts prognosis and treatment outcomes in triple-negative breast cancer. Frontiers in Immunology 2023; 14 doi: 10.3389/fimmu.2023.1200282
|
| 37 |
Noha A. Selem, Heba Nafae, Tamer Manie, Rana A. Youness, Mohamed Z. Gad. Let-7a/cMyc/CCAT1/miR-17–5p Circuit Re-sensitizes Atezolizumab Resistance in Triple Negative Breast Cancer through Modulating PD-L1. Pathology - Research and Practice 2023; 248: 154579 doi: 10.1016/j.prp.2023.154579
|
| 38 |
Rana A. Youness, Adham H. Mohamed, Eleni K. Efthimiadou, Radwa Y. Mekky, Maria Braoudaki, Sherif Ashraf Fahmy. A Snapshot of Photoresponsive Liposomes in Cancer Chemotherapy and Immunotherapy: Opportunities and Challenges. ACS Omega 2023; 8(47): 44424 doi: 10.1021/acsomega.3c04134
|
| 39 |
Rawan Amr Elmasri, Alaa A. Rashwan, Sarah Hany Gaber, Monica Mosaad Rostom, Paraskevi Karousi, Montaser Bellah Yasser, Christos K. Kontos, Rana A. Youness. Puzzling out the role of MIAT LncRNA in hepatocellular carcinoma. Non-coding RNA Research 2024; 9(2): 547 doi: 10.1016/j.ncrna.2024.01.006
|
| 40 |
Miao Miao, Henry Masengere, Guang Yu, Fengping Shan, Ziqing Li. Reevaluation of NOD/SCID Mice as NK Cell‐Deficient Models. BioMed Research International 2021; 2021(1) doi: 10.1155/2021/8851986
|
| 41 |
Noha M. Elemam, Radwa Y. Mekky, Gowhar Rashid, Maria Braoudaki, Rana A. Youness. Pharmacogenomic and epigenomic approaches to untangle the enigma of IL-10 blockade in oncology. Expert Reviews in Molecular Medicine 2024; 26 doi: 10.1017/erm.2023.26
|
| 42 |
Licia Rivoltini, Chiara Camisaschi, Giovanni Fucà, Biagio Paolini, Barbara Vergani, Valeria Beretta, Silvia Damian, Matteo Duca, Sara Cresta, Michele Magni, Biagio Eugenio Leone, Chiara Castelli, Filippo de Braud, Francesca De Santis, Massimo Di Nicola. Immunological characterization of a long-lasting response in a patient with metastatic triple-negative breast cancer treated with PD-1 and LAG-3 blockade. Scientific Reports 2024; 14(1) doi: 10.1038/s41598-024-54041-9
|